A firm base for drug development

Nature

Volumn 402, Issue 6761, 1999, Pages 471-472

  De Strooper, Bart ^a   König, Gerhard ^b  

^a DEPARTMENT OF PLANT SYSTEMS BIOLOGY   (Belgium)

^b BAYER AG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; ASPARTIC PROTEINASE; ASPARTIC PROTEINASE INHIBITOR; COMPLEMENTARY DNA; PRESENILIN 1; BACE1 PROTEIN, HUMAN; BACE2 PROTEIN, HUMAN; BETA SITE APP CLEAVING ENZYME 2; BETA-SITE APP CLEAVING ENZYME 2; ENZYME INHIBITOR; PROTEINASE; SECRETASE;

ALZHEIMER DISEASE; DRUG TARGETING; ENDOCYTOSIS; ENDOPLASMIC RETICULUM; ENDOSOME; ENZYME ACTIVE SITE; GOLGI COMPLEX; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; SHORT SURVEY; DRUG ANTAGONISM; ENZYMOLOGY; ISOLATION AND PURIFICATION; METABOLISM; NOTE;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; AMYLOID PRECURSOR PROTEIN SECRETASES; ASPARTIC ENDOPEPTIDASES; ENDOPEPTIDASES; ENZYME INHIBITORS; HUMANS;

EID: 0033518158     PISSN: 00280836     EISSN: None     Source Type: Journal    
DOI: 10.1038/44973     Document Type: Short Survey

References (9)

1. Haass, C. & Selkoe, D. J. Cell 75, 1039-1042 (1993).
2. Vassar, R. et al. Science 286, 735-741 (1999).
3. Hussain, I. et al. Mol. Cell. Neurosci. www.academicpress.com/www/journal/cn/mcne
4. Yan, R. et al. Nature 402, 533-537 (1999).
5. Sinha, S. et al. Nature 402, 537-540 (1999).
6. Price, D. L. et al. Annu. Rev. Genet. 32, 461-493 (1998).
7. Drews, J. Nature Biotechnol. 14, 1516-1518 (1996).
8. Ren, S. & Lien, E. J. Prog. Drug Res. 51, 3-31 (1998).
9. Lichtenthaler, S. F. et al. Proc. Natl Acad. Sci. USA 96, 3053-3058 (1999).